Revolution Medicines

Senior Scientist I, Cancer Genomics, Clinical Biomarker Development

Revolution Medicines$149K — $186K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • Ph.D. in Cancer Genomics, Genetics, Computational Biology, Bioinformatics, or similar field.
  • 2-8 years post-PhD experience in cancer genomics data analysis (post-doc, biotech, pharma, diagnostics).
  • Strong understanding of cancer biology, especially RAS/MAPK pathways in specific cancers.
  • Proficient in R and/or Python programming with version control skills (git).
  • Familiar with Linux, cloud services, and high-performance computing for genomics workflows.
  • Experience with ctDNA and other liquid biopsy data analysis.
  • Skilled in analyzing DNA sequence data from tumor tissues and applying various tools for analytics.

Responsibilities

  • Apply advanced analytics to clinical biomarker data to enhance research & development.
  • Integrate multi-omics datasets to deepen understanding of disease biology and treatment response.
  • Collaborate with cross-functional teams to provide insightful biomarker analyses and guide actions.
  • Communicate analytical results to both expert and lay audiences through publications and presentations.

Benefits

  • Robust equity awards and competitive cash compensation.
  • Significant learning and development opportunities.
  • Comprehensive health benefits and wellness programs.
Full Job Description
The Opportunity:

In this role you will join the Cancer Genomics group in Clinical Biomarker Development, which sits within the Translational Medicine department to develop biomarkers, technology, and computational strategies for our RAS(ON) inhibitor programs. You will drive the application of advanced genomics analyses to maximize insight generation from clinical samples in our Phase I-III studies. This role offers the chance to work in a collaborative and innovative environment, including on cross-functional teams with other computational scientists, biomarker leads, biostatisticians, and preclinical scientists.

As a Cancer Genomics Senior Scientist I in Clinical Biomarker Development, you will:
  • Apply advanced analytics and genomics solutions to clinical biomarker data to inform research & development
  • Integrate multi-omics datasets to interrogate disease biology and prognosis, mechanisms of resistance, and predict drug response
  • Collaborate with cross-functional teams, managing interactions with key stakeholders to deliver robust biomarker analyses and recommend follow-up actions
  • Communicate results to expert and non-expert audiences, including internal cross-functional team members and external collaborators, through scientific publications and presentations

Required Skills, Experience and Education:
  • A Ph.D. in Cancer Genomics, Genetics, Computational Biology, Bioinformatics, or similar degree.
  • A minimum of 2 - 8 years post-PhD experience analyzing cancer genomics data (post-doc, biotech, pharma, diagnostics, or combination).
  • A strong foundation in cancer biology, preferably with an understanding of RAS/MAPK signaling pathways in pancreatic, lung, or colorectal cancer.
  • Proficiency programming in R and/or Python, and expert in clearly documenting work with a version control system (git).
  • Experienced in Linux and the cloud, including HPC clusters and command line interface, and developing genomics workflows for large scale NGS datasets.
  • Experienced analyzing ctDNA or other liquid biopsy data derived from blood samples.
  • Experienced in the interrogation of DNA sequence data derived from tumor tissue, such as gene-panel, whole-exome or whole-genome data and downstream analytics (clonality estimates, copy number variation, chromosomal instability, mutational signatures, etc).
  • Practiced in commonly used tools and methods for DNA data analysis (GATK, Bioconductor, etc) and in utilizing publicly available datasets (TCGA, cBioPortal) to interrogate cancer genomics data.
  • Strong understanding of statistics and the ability to generate robust predictive models with multidimensional data.
  • Strong interpersonal, verbal and written communication skills; proactive, self-motivated, and adaptable in a dynamic environment.
  • Demonstrated ability to translate complex data into clear biological insight, and to influence project direction through data-driven scientific inquiry.

Preferred Skills:
  • Experienced analyzing clinical endpoints (ORR, PFS, OS) and/or experienced with clinico-genomic RWE analytics.
  • Longitudinal ctDNA data analysis for predicting clinical endpoints (ORR, PFS, OS).
  • Deep knowledge of pancreatic, lung, or colorectal cancer, preferably including how progression, response and resistance may be mediated by biomarkers detected in tissue and/or blood biomarkers.

#LI-Hybrid #LI-EM1

The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.

Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

Base Pay Salary Range

$149,000-$186,000 USD

We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.

Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.

If you believe you've been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.

About Revolution Medicines

Revolution Medicines is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with particular emphasis on RAS and mTOR signaling pathways. The company's proprietary platform enables the discovery and development of small molecules that bind covalently to proteins. Revolution Medicines was founded in 2014 and is headquartered in South San Francisco, California.
Learn more about Revolution Medicines
Size
201 employees
Market Cap
$2.1 billion
Industry
Net Income
-$108.1 million
Revenue
$42.9 million
NASDAQ

Similar Jobs

More Jobs at Revolution Medicines

More Pharmaceuticals & Biotech Jobs

Find similar Senior Scientist I, Cancer Genomics, Clinical Biomarker Development jobs: